Ultra-processed food intake and long-term risk of cardiovascular disease mortality among myocardial infarction patients: A prospective analysis of the Alpha Omega Cohort

Résumé fourni par la source

Background The impact of a diet high in ultra-processed foods (UPF) on mortality risk in patients with cardiovascular disease (CVD) remains unclear. Objective We examined the diet quality of a high UPF diet and its association with risk of total CVD mortality, ischemic heart disease (IHD) mortality, and stroke mortality in post- myocardial infraction (MI) patients. Methods We analyzed data from 4,365 post-MI patients in the Alpha Omega Cohort (79% men). Dietary intake at baseline was collected using a 203-item FFQ. Diet quality was assessed using the Dutch Healthy Diet Index adapted for CVD patients (DHD-CVD, range 0-160). UPF were identified and categorized according to the Nova classification system. Q1 and Q4 of %g/day of UPF represented a low and a high ultra-processed diet, respectively. HRs for CVD, IHD and stroke mortality were obtained from multivariable Cox regression models. Results Mean UPF contribution to the diet was 18%g/day (Q1 vs Q4=9 vs 29%g/day). Compared to Q1, patients in Q4 had higher intakes of total energy, and lower intakes of fruit and vegetables. DHD-CVD scores decreased slightly across quartiles (Q1 vs Q4=95 vs 82). Over a median follow-up of 14 years, 1,012 patients died from CVD (659 from IHD, 208 from stroke). Compared to Q1, a high ultra-processed diet was not consistently or significantly associated with CVD and IHD mortality. However, it was associated with a higher risk of stroke mortality (HR per10% point increase : 1.21, 95% CI: 1.02-1.42). This association was stronger in older patients, women, and those with a higher BMI, lower physical activity levels, and lower socio-economic status and robust to sensitivity analysis. Conclusions In post-MI patients, a high UPF diet was lower in whole, cardio-protective foods. Our study highlights the adverse association of a high UPF diet with stroke mortality risk among patients that have previously experienced an MI.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.